Viewing Study NCT06650332


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2025-12-30 @ 2:03 AM
Study NCT ID: NCT06650332
Status: RECRUITING
Last Update Posted: 2024-10-21
First Post: 2024-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module